No PhD Needed: Claude Grabs AI Drug Discovery Models

SandboxAQ is turning Claude into a front door for scientific models, betting AI drug discovery needs easier access more than hype.

Key takeaways

• If AI drug discovery models are already powerful, why does so much of their value still sit behind specialist infrastructure, code, and computational workflows?
• That is the real question behind SandboxAQ’s tie-up with Anthropic. The company is integrating its Large Quantitative Models, or LQMs, with Claude,...
• Is SandboxAQ Competing on Better Models, or Better Access to Them?
• SandboxAQ is not simply pitching another AI model for pharma. It is making a distribution argument.

👉 Read the full breakdown on MLXIO

Canonical source: https://mlxio.com/ai-ml/sandboxaq-claude-drug-discovery